ATLANTA, July 1 /PRNewswire/ — The refinements in
Elekta’s Gamma Knife®
surgery technology that created the fifth generation Leksell Gamma
Knife® Perfexion™ are radically changing the approach to
treating brain metastases and
other brain disorders. With Perfexion, physicians are applying
therapy to multiple metastases (mets) in a single session, treating
more non-malignant targets located in critical areas and planning
increasingly tailored plans to meet individual
patient needs. The result has been an upsurge in Perfexion
sales and upgrades from the previous model Leksell Gamma Knife®
4C in North America.
Elekta recently announced its fourth quarter orders for Leksell
Gamma Knife Perfexion, including Methodist Hospital (San Antonio), Memorial Hermann-Texas
Medical Center (Houston), New
York-Presbyterian Hospital and Swedish Cancer Institute (Seattle).
“Since the introduction of Perfexion, 40 percent of Gamma Knife
systems in North America are, or
wi
‘/>”/>
SOURCE